Autolus Therapeutics plc
IPOAutolus - developing CAR T cell therapies for patients with cancer and autoimmune diseases
Public · London, United Kingdom · Founded 2014 · $80.0M raised
- Headquarters
- London
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- autolus.com
- Total Funding
- $80.0M
- Last Round
- $80.0M Series CSep 2017
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing advanced CAR T cell therapies for the treatment of cancer and autoimmune diseases.
Summary
Autolus Therapeutics plc is a Biotech company based in London, United Kingdom, founded in 2014. It has raised $80.0M in total across 1 round, most recently a $80.0M Series C round in Sep 2017. Investors include Syncona Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2018
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...